Global Donor Egg IVF Treatment Market Growth (Status and Outlook) 2025-2031

According to this study, the global Donor Egg IVF Treatment market size will reach US$ million by 2031.

Donor egg IVF treatment involves retrieving of healthy viable eggs from donorsbelow 33 years of age and fertilized with sperms in vitro in fertility clinics. Theembryo is then placed in the recipient"s womb.

United States market for Donor Egg IVF Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Donor Egg IVF Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Donor Egg IVF Treatment is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Donor Egg IVF Treatment players cover Cook Medical, Inc., EMD Serono, Inc., Flinders Reproductive Medicine Pty. Ltd., Fertility First, Genea Oxford Fertility Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Donor Egg IVF Treatment Industry Forecast” looks at past sales and reviews total world Donor Egg IVF Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Donor Egg IVF Treatment sales for 2025 through 2031. With Donor Egg IVF Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Donor Egg IVF Treatment industry.

This Insight Report provides a comprehensive analysis of the global Donor Egg IVF Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Donor Egg IVF Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Donor Egg IVF Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Donor Egg IVF Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Donor Egg IVF Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Donor Egg IVF Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:
Fresh Donor Egg IVF Cycle
Frozen Donor Egg IVF Cycle

Segmentation by Application:
Fertility Clinics
Hospital
Surgical Centers
Clinical Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cook Medical, Inc.
EMD Serono, Inc.
Flinders Reproductive Medicine Pty. Ltd.
Fertility First
Genea Oxford Fertility Limited
OvaScience
Procrea Fertility
Progyny, Inc.
ReproMed
Vitrolife AB

Please note: The report will take approximately 2 business days to prepare and deliver. Show more